Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
SFDA · 6 medicines · Historical list
HSA · 6 medicines
AEMPS · 5 medicines
FDA · 2 medicines
Anvisa · 1 medicine
EMA · 1 medicine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
6 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| REXULTI 1 mg Tablet | Saudi Arabia | Authorised | Otsuka Pharmaceutical Co., Ltd. | ||
| REXULTI 2 mg Tablet | Saudi Arabia | Authorised | Otsuka Pharmaceutical Co., Ltd. | ||
| REXULTI 3 mg Tablet | Saudi Arabia | Authorised | Otsuka Pharmaceutical Co., Ltd. | ||
| REXULTI 4 mg Tablet | Saudi Arabia | Authorised | Otsuka Pharmaceutical Co., Ltd. | ||
| REXULTI 0.5 mg Tablet | Saudi Arabia | Authorised | Otsuka Pharmaceutical Co., Ltd. | ||
| REXULTI 0.25 mg Tablet | Saudi Arabia | Authorised | Otsuka Pharmaceutical Co., Ltd. |
The same brand on several registers.
The companies holding its medicines, the most first.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, Anvisa, CBG-MEB, EMA, FDA, HALMED, Health Canada, HSA and SFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
